Abstract
Purpose
The aim of this study was to investigate symptom clusters and associated clinical factors in ambulatory multiple myeloma patients undergoing medication therapy. We also aimed to determine the correlations between symptom clusters and patient quality of life.
Methods
A total of 174 multiple myeloma patients hospitalized in the haematology day unit were included in this study. A cross-sectional survey was conducted to examine symptoms and quality of life. Symptoms were assessed by the Chinese version of the Condensed Memorial Symptom Assessment Scale. Quality of life was measured with the Functional Assessment of Cancer Therapy-General. Principal component analysis was used to identify symptom clusters. Independent-samples t tests and chi-square tests were used for comparisons between groups. Spearman’s rank correlation analysis was used to identify correlations.
Results
We identified three symptom clusters in multiple myeloma patients: psychological; pain, dry mouth, and difficulty sleeping; and fatigue symptom cluster. For each symptom cluster, the patients could be categorized into a severe-symptom group or a mild-symptom group based on the distress of symptoms. The patients in each group exhibited differential demographic and clinical features. Symptom cluster distress was adversely correlated with patients’ quality of life.
Conclusions
Ambulatory multiple myeloma patients undergoing anticancer medication therapy experience multiple symptoms, which can be categorized into three symptom clusters. For each symptom cluster, level of distress was associated with patients’ demographic and clinical characteristics. The presence and level of distress of these symptom clusters have adverse impacts on patients’ quality of life.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request. The data are not publicly available due to privacy or ethical restrictions.
Code availability
Not applicable.
References
Cowan AJ, Allen C, Barac A, Basaleem H, Bensenor I, Curado MP, Foreman K, Gupta R, Harvey J, Hosgood HD et al (2018) Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016. JAMA Oncol 4(9):1221–1227. https://doi.org/10.1001/jamaoncol.2018.2128
Siegel RL, Miller KD (2020) Jemal A (2020) Cancer statistics. CA Cancer J Clin 70(1):7–30. https://doi.org/10.3322/caac.21590
Rajkumar SV (2020) Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol 95(5):548–567. https://doi.org/10.1002/ajh.25791
Kumar SK, Jacobus SJ, Cohen AD, Weiss M, Callander N, Singh AK, Parker TL, Menter A, Yang X, Parsons B et al (2020) Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial. Lancet Oncol 21(10):1317–1330. https://doi.org/10.1016/S1470-2045(20)30452-6
Dodd M, Janson S, Facione N, Faucett J, Froelicher ES, Humphreys J, Lee K, Miaskowski C, Puntillo K, Rankin S et al (2001) Advancing the science of symptom management. J Adv Nurs 33(5):668–676. https://doi.org/10.1046/j.1365-2648.2001.01697.x
Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN (2006) Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage 31(1):85–95. https://doi.org/10.1016/j.jpainsymman.2005.05.015
Russell J, Wong ML, Mackin L, Paul SM, Cooper BA, Hammer M, Conley YP, Wright F, Levine JD, Miaskowski C (2019) Stability of symptom clusters in patients with lung cancer receiving chemotherapy. J Pain Symptom Manage 57(5):909–922. https://doi.org/10.1016/j.jpainsymman.2019.02.002
Li H, Sereika SM, Marsland AL, Conley YP, Bender CM (2020) Symptom clusters in women with breast cancer during the first 18 months of adjuvant therapy. J Pain Symptom Manage 59(2):233–241. https://doi.org/10.1016/j.jpainsymman.2019.10.002
Chen F, Leng Y, Zhang L, Xu J, Zhang D, Qin Y, Li J, Zheng Y (2020) The correlation of symptom clusters and functional performance in adult acute leukemia patients under chemotherapy. Cancer Nurs. https://doi.org/10.1097/NCC.0000000000000816
Kwekkeboom KL (2016) Cancer symptom cluster management. Semin Oncol Nurs 32(4):373–382. https://doi.org/10.1016/j.soncn.2016.08.004
Jordan K, Proskorovsky I, Lewis P, Ishak J, Payne K, Lordan N, Kyriakou C, Williams CD, Peters S, Davies FE (2014) Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study. Support Care Cancer 22(2):417–426. https://doi.org/10.1007/s00520-013-1991-4
Ramsenthaler C, Gao W, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ (2019) Symptoms and anxiety predict declining health-related quality of life in multiple myeloma: a prospective, multi-centre longitudinal study. Palliat Med 33(5):541–551. https://doi.org/10.1177/0269216319833588
Ramsenthaler C, Kane P, Gao W, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ (2016) Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis. Eur J Haematol 97(5):416–429. https://doi.org/10.1111/ejh.12790
Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L, Richardson P, Caltagirone S, Lahuerta JJ, Facon T et al (2015) Revised international staging system for multiple myeloma: a report from international myeloma working group. J Clin Oncol 33(26):2863–2869. https://doi.org/10.1200/JCO.2015.61.2267
Chang VT, Hwang SS, Kasimis B, Thaler HT (2004) Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS). Cancer Invest 22(4):526–536. https://doi.org/10.1081/cnv-200026487
Lam WW, Law CC, Fu YT, Wong KH, Chang VT, Fielding R (2008) New insights in symptom assessment: the Chinese Versions of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) and the Condensed MSAS (CMSAS). J Pain Symptom Manage 36(6):584–595. https://doi.org/10.1016/j.jpainsymman.2007.12.008
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579. https://doi.org/10.1200/JCO.1993.11.3.570
Yu CL, Fielding R, Chan CL, Tse VK, Choi PH, Lau WH, Choy DT, O SK, Lee AW, Sham JS, (2000) Measuring quality of life of Chinese cancer patients: a validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale. Cancer 88(7):1715–1727
Barsevick A (2016) Defining the symptom cluster: how far have we come? Semin Oncol Nurs 32(4):334–350. https://doi.org/10.1016/j.soncn.2016.08.001
Lim KE, Kim SR, Kim HK, Kim SR (2017) Symptom clusters and quality of life in subjects with COPD. Respir Care 62(9):1203–1211. https://doi.org/10.4187/respcare.05374
Hauksdottir B, Klinke ME, Gunnarsdottir S, Bjornsdottir K (2017) Patients’ experiences with multiple myeloma: a meta-aggregation of qualitative studies. Oncol Nurs Forum 44(2):E64–E81. https://doi.org/10.1188/17.ONF.E64-E81
van der Poel MW, Oerlemans S, Schouten HC, van de Poll-Franse LV (2015) Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry. Ann Hematol 94(4):651–661. https://doi.org/10.1007/s00277-014-2264-0
Guo M, Wang C, Yin X, Nie L, Wang G (2019) Symptom clusters and related factors in oesophageal cancer patients 3 months after surgery. J Clin Nurs 28(19–20):3441–3450. https://doi.org/10.1111/jocn.14935
Rha SY, Park M, Lee J (2019) Stability of symptom clusters and sentinel symptoms during the first two cycles of adjuvant chemotherapy. Support Care Cancer 27(5):1687–1695. https://doi.org/10.1007/s00520-018-4413-9
Zucca AC, Boyes AW, Linden W, Girgis A (2012) All’s well that ends well? Quality of life and physical symptom clusters in long-term cancer survivors across cancer types. J Pain Symptom Manage 43(4):720–731. https://doi.org/10.1016/j.jpainsymman.2011.04.023
Mathias JL, Cant ML, Burke ALJ (2018) Sleep disturbances and sleep disorders in adults living with chronic pain: a meta-analysis. Sleep Med 52:198–210. https://doi.org/10.1016/j.sleep.2018.05.023
Krause AJ, Prather AA, Wager TD, Lindquist MA, Walker MP (2019) The pain of sleep loss: a brain characterization in humans. J Neurosci 39(12):2291–2300. https://doi.org/10.1523/JNEUROSCI.2408-18.2018
Kiely F, Cran A, Finnerty D, O’Brien T (2017) Self-reported quality of life and symptom burden in ambulatory patients with multiple myeloma on disease-modifying treatment. Am J Hosp Palliat Care 34(7):671–676. https://doi.org/10.1177/1049909116646337
Zaleta AK, Miller MF, Olson JS, Yuen EYN, LeBlanc TW, Cole CE, McManus S, Buzaglo JS (2020) Symptom burden, perceived control, and quality of life among patients living with multiple myeloma. J Natl Compr Canc Netw 18(8):1087–1095. https://doi.org/10.6004/jnccn.2020.7561
Jean-Baptiste M, Gries KS, Lenderking WR, Fastenau J (2020) Symptom burden and health-related quality of life impacts of smoldering multiple myeloma: the patient perspective. J Patient Rep Outcomes 4(1):95. https://doi.org/10.1186/s41687-020-00253-2
Xu X, Ou M, Xie C, Cheng Q, Chen Y (2019) Pain acceptance and its associated factors among cancer patients in Mainland China: a cross-sectional study. Pain Res Manag 2019:9458683. https://doi.org/10.1155/2019/9458683
Santoso AMM, Jansen F, Lissenberg-Witte BI, Baatenburg de Jong RJ, Langendijk JA, Leemans CR, Smit JH, Takes RP, Terhaard CHJ, van Straten A et al (2021) Poor sleep quality among newly diagnosed head and neck cancer patients: prevalence and associated factors. Support Care Cancer 29(2):1035–1045. https://doi.org/10.1007/s00520-020-05577-9
Bartley EJ, Fillingim RB (2013) Sex differences in pain: a brief review of clinical and experimental findings. Br J Anaesth 111(1):52–58. https://doi.org/10.1093/bja/aet127
Ohayon MM (2002) Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6(2):97–111. https://doi.org/10.1053/smrv.2002.0186
Feldman EL, Nave KA, Jensen TS, Bennett DLH (2017) New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain. Neuron 93(6):1296–1313. https://doi.org/10.1016/j.neuron.2017.02.005
Chen SY, Wang Y, Zhang CL, Yang ZM (2020) Decreased basal and stimulated salivary parameters by histopathological lesions and secretory dysfunction of parotid and submandibular glands in rats with type 2 diabetes. Exp Ther Med 19(4):2707–2719. https://doi.org/10.3892/etm.2020.8505
Reutrakul S, Mokhlesi B (2017) Obstructive sleep apnea and diabetes: a state of the art review. Chest 152(5):1070–1086. https://doi.org/10.1016/j.chest.2017.05.009
Ogilvie RP, Patel SR (2018) The epidemiology of sleep and diabetes. Curr Diab Rep 18(10):82. https://doi.org/10.1007/s11892-018-1055-8
Mols F, Oerlemans S, Vos AH, Koster A, Verelst S, Sonneveld P, van de Poll-Franse LV (2012) Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry. Eur J Haematol 89(4):311–319. https://doi.org/10.1111/j.1600-0609.2012.01831.x
Kamal M, Wang XS, Shi Q, Zyczynski TM, Davis C, Williams LA, Lin HK, Garcia-Gonzalez A, Cleeland CS, Orlowski R (2021) Symptom burden and its functional impact in patients with “symptomatic” relapsed or refractory multiple myeloma. Support Care Cancer 29(1):467–475. https://doi.org/10.1007/s00520-020-05493-y
Hwang KH, Cho OH, Yoo YS (2016) Symptom clusters of ovarian cancer patients undergoing chemotherapy, and their emotional status and quality of life. Eur J Oncol Nurs 21:215–222. https://doi.org/10.1016/j.ejon.2015.10.007
Baden M, Lu L, Drummond FJ, Gavin A, Sharp L (2020) Pain, fatigue and depression symptom cluster in survivors of prostate cancer. Support Care Cancer 28(10):4813–4824. https://doi.org/10.1007/s00520-019-05268-0
Nho JH, Kim SR, Park MH, Kweon SS (2018) Symptom clusters and quality of life in breast cancer survivors after cancer treatment in a tertiary hospital in Korea. Eur J Cancer Care (Engl) 27(6):e12919. https://doi.org/10.1111/ecc.12919
Funding
This work was supported by grants to F.C. from the West China Nursing Discipline Development Special Fund Project of Sichuan University (grant number HXHL19039) and Sichuan Provincial Health Committee Research Grant (grant number 16PJ350) and grants to Y.Z. from the National Science Foundation of China (grant number 82070219), Science and Technology Department of Sichuan Province (grant number 2019YJ0028), and the Sichuan University Faculty Start Fund.
Author information
Authors and Affiliations
Contributions
Conceptualization: Yamei Leng; methodology: Fengjiao Chen; formal analysis and investigation: Jingyao Ni, Li Zhang; writing (original draft preparation): Fengjiao Chen; writing (review and editing): Yuhuan Zheng, Jiping Li; funding acquisition: Fengjiao Chen, Yuhuan Zheng; resources: Yamei Leng, Ting Niu; supervision: Jiping Li.
Corresponding authors
Ethics declarations
Ethics approval
Approval was obtained from the Biomedical Research Ethical Committee of West China Hospital (no. 2019504). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chen, F., Leng, Y., Ni, J. et al. Symptom clusters and quality of life in ambulatory patients with multiple myeloma. Support Care Cancer 30, 4961–4970 (2022). https://doi.org/10.1007/s00520-022-06896-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-022-06896-9